This is a preview of subscription content, access via your institution
Subscribe to Journal
Get full journal access for 1 year
only $14.88 per issue
All prices are NET prices.
VAT will be added later in the checkout.
Tax calculation will be finalised during checkout.
Get time limited or full article access on ReadCube.
All prices are NET prices.
Department of Reproductive Health and Research. Gender and reproductive rights: sexual health. World Health Organization. Available at: http://www.who.int/reproductive-health/gender/sexual_health.html. Accessed November 25, 2003.
NIH Consensus Conference. Impotence. NIH Consensus Development Panel on Impotence. JAMA 1993; 270: 83–90.
Althof SE . Quality of life and erectile dysfunction. Urology 2002; 59: 803–810.
Martin-Morales A et al. Prevalence and independent risk factors for erectile dysfunction in Spain: results of the Epidemiologia de la Disfuncion Erectil Masculina Study. J Urol 2001; 166: 569–574, discussion 574–575.
Aytaç IA, McKinlay JB, Krane RJ . The likely worldwide increase in erectile dysfunction between 1995 and 2025 and some possible policy consequences. BJU Int 1999; 84: 50–56.
Moncada I, Saenz de Tejada I . Vascular physiology of penile erection. In: Carson C, Kirby R, Goldstein I (eds). Textbook of Erectile Dysfunction. Isis Medical Media: Oxford, 1999, pp 51–57.
Lue TF . Erectile dysfunction. N Engl J Med 2000; 342: 1802–1813.
Moreland RB . Is there a role of hypoxemia in penile fibrosis: a viewpoint presented to the Society for the Study of Impotence. Int J Impot Res 1998; 10: 113–120.
Keene LC, Davies PH . Drug-related erectile dysfunction. Adverse Drug React Toxicol Rev 1999; 18: 5–24.
Burls A, Gold L, Clark W . Systematic review of randomised controlled trials of sildenafil (Viagra) in the treatment of male erectile dysfunction. Br J Gen Pract 2001; 51: 1004–1012.
Fink HA et al. Sildenafil for male erectile dysfunction: a systematic review and meta-analysis. Arch Intern Med 2002; 162: 1349–1360.
Brock GB et al. Efficacy and safety of tadalafil for the treatment of erectile dysfunction: results of integrated analyses. J Urol 2002; 168: 1332–1336.
Porst H et al. The efficacy and tolerability of vardenafil, a new, oral, selective phosphodiesterase type 5 inhibitor, in patients with erectile dysfunction: the first at-home clinical trial. Int J Impot Res 2001; 13: 192–199.
Hellstrom WJ et al. Vardenafil for treatment of men with erectile dysfunction: efficacy and safety in a randomized, double-blind, placebo-controlled trial. J Androl 2002; 23: 763–771.
Heaton JP . Apomorphine: an update of clinical trial results. Int J Impot Res 2000; 12(Suppl 4): S67–S73.
About this article
Cite this article
Moncada, I. Document for the general public. Int J Impot Res 16 (Suppl 2), S7–S9 (2004). https://doi.org/10.1038/sj.ijir.3901236
- sexual health